Ayurcann Holdings Revenue

Ayurcann Holdings had revenue of 8.48M CAD in the quarter ending September 30, 2025, with 2.07% growth. This brings the company's revenue in the last twelve months to 31.28M, up 15.88% year-over-year. In the fiscal year ending June 30, 2025, Ayurcann Holdings had annual revenue of 31.11M with 23.66% growth.

Revenue (ttm)

31.28M

Revenue Growth

+15.88%

P/S Ratio

0.06

Revenue / Employee

n/a

Employees

n/a

Market Cap

1.95M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	31.11M	5.95M	23.66%
Jun 30, 2024	25.16M	12.67M	101.39%
Jun 30, 2023	12.49M	3.11M	33.09%
Jun 30, 2022	9.39M	1.75M	22.96%
Jun 30, 2021	7.63M	7.02M	1,147.68%
Jun 30, 2020	Pro	Pro	Pro
Jun 30, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
RAMM Pharma	3.36M
Planet Based Foods Global	-356.97K
Aion Therapeutic	1.47M
Ovation Science	63.82K
Genix Pharmaceuticals	68.00
Adastra Holdings	16.86M
Vencanna Ventures	3.60M

Revenue Rankings